Going Green &Ndash; Treatment Outcome and Safety Profile of Chronic Central Serous Chorioretinopathy Treated With Subthreshold Green Laser

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s180663
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Indocyanine Green Angiographic Findings in Central Serous Chorioretinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
1995English

Exome Sequencing in Families With Chronic Central Serous Chorioretinopathy

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Microsecond Yellow Laser for Subfoveal Leaks in Central Serous Chorioretinopathy

Clinical Ophthalmology
Ophthalmology
2016English

Central Serous Chorioretinopathy: Pathogenesis and Management

Clinical Ophthalmology
Ophthalmology
2019English

Corticosteroids, Central Serous Chorioretinopathy, and Neurocysticercosis

Archives of Ophthalmology
2004English

Green Banking: Going Green

International Journal of Economics, Finance and Management Sciences
2015English

Intravitreal Triamcinolone Acetonide and Central Serous Chorioretinopathy

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Eplerenone for Chronic Central Serous Chorioretinopathy-A Randomized Controlled Prospective Study

Acta Ophthalmologica
MedicineOphthalmology
2017English

Central Serous Chorioretinopathy With and Without Steroids: A Multicenter Survey

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy